Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS

被引:293
作者
Biggar, Robert J.
Jaffe, Elaine S.
Goedert, James J.
Chaturvedi, Anil
Pfeiffer, Ruth
Engels, Eric A.
机构
[1] NCI, Biostat Branch, NIH, Dept Hlth & Human Serv, Bethesda, MD USA
[2] NCI, Viral Epidemiol Branch, Div Canc Epidemiol & Genet, Lab Pathol,NIH,Dept Hlth & Human Serv, Bethesda, MD USA
关键词
D O I
10.1182/blood-2006-05-024109
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In persons with HIV/AIDS (PWHAs), Hodgkin lymphoma (HL) risk is increased. However, HL incidence in PWHAs has unexpectedly increased since highly active antiretroviral therapy (HAART) was introduced. We linked nationwide HIV/AIDS and cancer registry data from 1980 through 2002. Immunity was assessed by CD4 T-lymphocyte counts at AIDS onset. Annual HL incidence rates were calculated for 4 through 27 months after AIDS onset. During 477 368 person years (py's) of follow-up in 317 428 persons with AIDS (PWAS), 173 HL cases occurred (36.2 per 105 py's). Incidence was significantly higher in 1996 to 2002 than earlier. Incidence in PWAs with 150 to 199 CD4 cells/mu L was 53.7 per 10(5) py's, whereas in PWAs with fewer than 50 CD4 cells/mu L, it was 20.7 per 10(5) py's (P-trend = .002). For each HL subtype, incidence decreased with declining CD4 counts, but nodular sclerosing decreased more precipitously than mixed cellularity, thereby increasing the proportion of mixed cellularity HL seen in PWAs. We conclude that HL incidence is lower with severe immunosuppression than with moderate immunosuppression, and HAART-related improvements in CD4 counts likely explain the increasing HL incidence in PWHAS observed since 1996. With more severe immunosuppression, nodular sclerosing HL becomes infrequent, explaining the higher proportion of mixed cellularity HL found in PWAs. Pathogenesis implications are discussed.
引用
收藏
页码:3786 / 3791
页数:6
相关论文
共 39 条
[1]  
Appleby P, 2000, JNCI-J NATL CANCER I, V92, P1823, DOI 10.1093/jnci/92.22.1823
[2]   Cancer risk in elderly persons with HIV/AIDS [J].
Biggar, RJ ;
Kirby, KA ;
Atkinson, T ;
McNeel, TS ;
Engels, E .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 36 (03) :861-868
[3]   CANCER IN A GROUP AT RISK OF ACQUIRED-IMMUNODEFICIENCY-SYNDROME (AIDS) THROUGH 1984 [J].
BIGGAR, RJ ;
HORM, J ;
GOEDERT, JJ ;
MELBYE, M .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1987, 126 (04) :578-586
[4]  
BORGES HT, 2001, J REGISTRY MANAGEMEN, V28, P89
[5]   Molecular profiling provides evidence of primary mediastinal large B-cell lymphoma as a distinct entity related to classic Hodgkin lymphoma [J].
Calvo, KR ;
Traverse-Glehen, A ;
Pittaluga, S ;
Jaffe, ES .
ADVANCES IN ANATOMIC PATHOLOGY, 2004, 11 (05) :227-238
[6]  
*CDCP, 2002, MMWR-MORBID MORTAL W, V51, P592
[7]  
Chan WC, 2001, HEMATOL ONCOL, V19, P1
[8]   Cancer risk in the swiss HIV cohort study: Associations with immunodeficiency, smoking, and highly active antiretroviral therapy [J].
Clifford, GM ;
Polesel, J ;
Rickenbach, M ;
Dal Maso, L ;
Keiser, O ;
Kofler, A ;
Rapiti, E ;
Levi, F ;
Jundt, G ;
Fisch, T ;
Bordoni, A ;
De Weck, D ;
Franceschi, S .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (06) :425-432
[9]   Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the United States [J].
Cunningham, WE ;
Markson, LE ;
Andersen, RM ;
Crystal, SH ;
Fleishman, JA ;
Golin, C ;
Gifford, A ;
Liu, HHH ;
Nakazono, TT ;
Morton, S ;
Bozzette, SA ;
Shapiro, MF ;
Wenger, NS .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 25 (02) :115-123
[10]   Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis [J].
Detels, R ;
Tarwater, P ;
Phair, JP ;
Margolick, J ;
Riddler, SA ;
Muñoz, A .
AIDS, 2001, 15 (03) :347-355